Modelling in economic evaluation: an unavoidable fact of life.

M J Buxton, M F Drummond, B A van Hout, R L Prince, T A Sheldon, T Szucs, M Vray

Research output: Contribution to journalArticlepeer-review

Abstract

The role of modelling in economic evaluation is explored by discussing, with examples, the uses of models. The expanded use of pragmatic clinical trials as an alternative to models is discussed. Some suggestions for good modelling practice are made. (C) 1997 by John Wiley & Sons, Ltd.
Original languageEnglish
Pages (from-to)217-27
Number of pages11
JournalHealth Economics
Volume6
Issue number3
Publication statusPublished - 1997

Keywords

  • cost-effectiveness analysis
  • resource allocation
  • decision trees
  • economic evaluation
  • clinical trials
  • SEROTONIN REUPTAKE INHIBITORS
  • ACUTE MYOCARDIAL-INFARCTION
  • CORONARY HEART-DISEASE
  • COST-EFFECTIVENESS
  • PROPHYLACTIC USE
  • GASTRIC-ULCER
  • DOUBLE-BLIND
  • THERAPY
  • METAANALYSIS
  • PREVENTION

Cite this